IP Verse

Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex

Patent No. EP3641819 (titled "Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex") was filed by GW Research on Jun 21, 2018. The application was issued on Oct 11, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KRAUS & LEDERERJul 9, 2024KRAUS & LEDERER
KRAUS & LEDERER PARTGMBBJul 9, 2024KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3641819

GW RESEARCH
Application Number
EP18737374A
Filing Date
Jun 21, 2018
Status
Revoked
Jun 19, 2026
Publication Date
Oct 11, 2023
External Links
Slate, Register , Google Patents